Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-11

Clinical Trial Update: Shengyu Decoction and Lijin Manipulation for Knee OA: 3D Gait Analysis [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial evaluating Shengyu Decoction and Lijin Manipulation for knee osteoarthritis, employing 3D gait analysis, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lijin Manipulation
  • Shengyu Decoction

Snippet

Sponsor: Xuhui Central Hospital, Shanghai | Conditions: Osteoarthritis of the Knee | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION